Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with Trump order on gender.

The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight ...

BLACKSBURG, Va. (WDBJ) - Earlier this year, the Food and Drug Administration (FDA) banned the use of Red No.3 dye. This is ...

For executives racing to lead in healthcare AI, I see the European Union, the United States and China as the leading ...

v) Prepare and file a NDA for marketing approval of XORLO™.